Cargando…

Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study

BACKGROUND: Aggressive non-melanoma skin cancer (deeply infiltrating, recurrent, and morphea form lesions) are therapeutically challenging because they require considerable tissue loss and may demand radical disfiguring surgery. Interferons (IFN) may provide a non-surgical approach to the management...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anasagasti-Angulo, Lorenzo, Garcia-Vega, Yanelda, Barcelona-Perez, Silvia, Lopez-Saura, Pedro, Bello-Rivero, Iraldo
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724551/ https://www.ncbi.nlm.nih.gov/pubmed/19643007 http://dx.doi.org/10.1186/1471-2407-9-262

Ejemplares similares

Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers
por: García-García, Idrian, et al.
Publicado: (2016)

Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial
por: García-Vega, Yanelda, et al.
Publicado: (2012)

A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG
por: Miranda, Jamilet, et al.
Publicado: (2023)

Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study
por: García-García, Idrian, et al.
Publicado: (2010)

Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG
por: Vázquez-Blomquist, Dania, et al.
Publicado: (2022)

Construction, purification, and characterization of a chimeric TH1 antagonist
por: Bello-Rivero, Iraldo, et al.
Publicado: (2006)

Previous contraceptive treatment relates to grey matter volumes in the hippocampus and basal ganglia
por: Pletzer, Belinda, et al.
Publicado: (2019)

Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study
por: Milanés-Virelles, María T, et al.
Publicado: (2008)

Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon
por: Fernández-Fournier, Mireya, et al.
Publicado: (2015)

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
por: Costa, Marisa Boff, et al.
Publicado: (2018)

IN VITRO ASSESSMENT OF THE BIOLOGIC ACTIVITY OF INTERFERON BETA FORMULATIONS USED FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS
por: Scagnolari, Carolina, et al.
Publicado: (2014)

New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
por: Villani, Alessia, et al.
Publicado: (2022)

Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia
por: Nuruddin, Murtuza, et al.
Publicado: (2022)

Seasonality of diagnosis of squamous and basal cell skin cancers in Tasmania, Australia.
por: Armstrong, B. K., et al.
Publicado: (1986)

Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
por: Sainz, Bruno, et al.
Publicado: (2005)

Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections
por: Ianevski, Aleksandr, et al.
Publicado: (2021)

Una monarquía protegida por la censura /
por: Anasagasti, Iñaki
Publicado: (2009)

Treatment of primary squamous cell carcinoma of the endometrium and review of previous literature: A case report
por: Song, Liyun, et al.
Publicado: (2023)

Interferon and Interferon Inducers in the Treatment of Malignancies
por: Levy, Hilton B., et al.
Publicado: (1970)

Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia
por: Ghaffari, Reza, et al.
Publicado: (2021)

Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma
por: Ascierto, Paolo A, et al.
Publicado: (2022)

Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma
por: Saito, Tomoko, et al.
Publicado: (2014)

The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work.
por: Beral, V., et al.
Publicado: (1981)

Non-solar ultraviolet radiation and the risk of basal and squamous cell skin cancer.
por: Bajdik, C. D., et al.
Publicado: (1996)

The relationship between basal and squamous cell skin cancer and smoking related cancers
por: Sitas, Freddy, et al.
Publicado: (2011)

Formulation of Chrysomycin A Cream for the Treatment of Skin Infections
por: Liu, Haohua, et al.
Publicado: (2022)

Enseñanza de la arquitectura : cultura moderna técnico artística /
por: Anasagasti, Teodoro de
Publicado: (1995)

Synergistic Antihyperglycemic and Antihyperlipidemic Effect of Polyherbal and Allopolyherbal Formulation
por: Alhamhoom, Yahya, et al.
Publicado: (2023)

Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation
por: Castro, Leonor S., et al.
Publicado: (2021)

Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids
por: Hakim, Mohamad S., et al.
Publicado: (2018)

Interferon and interferon-stimulated genes in HBV treatment
por: Li, Qirong, et al.
Publicado: (2022)

Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality
por: Prikhnenko, Sergey
Publicado: (2015)

TUMOR RECURRENCE FIVE YEARS AFTER TREATMENT OF CUTANEOUS BASAL CELL CARCINOMA AND SQUAMOUS CELL CARCINOMA
por: Chren, Mary-Margaret, et al.
Publicado: (2012)

Treatment outcome with interferon alpha 2b in ocular surface squamous neoplasia: Recommendation as primary treatment by peripheral ophthalmologists
por: Meel, Rachna, et al.
Publicado: (2021)

Note on the Treatment of Squamous Diseases of the Skin
por: Dey, Ockhoy Coomar
Publicado: (1867)

Synergistic treatment of TS
por: Gurkar, Aditi U., et al.
Publicado: (2017)

Reduced Basal ATP Synthetic Flux of Skeletal Muscle in Patients with Previous Acromegaly
por: Szendroedi, Julia, et al.
Publicado: (2008)

Comparación de dos métodos de criopreservacion de tejido testicular bovino
por: Lepe Anasagasti, Itziar Eukene
Publicado: (2019)

Gel Formulations for Topical Treatment of Skin Cancer: A Review
por: Slavkova, Marta, et al.
Publicado: (2023)

Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation
por: Panigrahi, Rajesh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nti09cv72pi629tvprihv1qgpg